We are Tikva Allocell

Tikva Allocell founded on 1st of July 2023.

Tikva is a late-stage pre-clinical stage biotech company founded by seasoned cell and gene therapy key opinion leaders. We are headquartered in Singapore, integrating with local academic environment with close collaboration with Baylor College of Medicine.
We endeavor to develop highly differentiated “off-the-shelf” cell therapy for solid tumors with plans to set up clinical trials in the USA and Singapore.

Share the Post:

Related Posts